AXDX logo

Accelerate Diagnostics (AXDX) Accounts Receivable

Annual Accounts Receivable

$2.62 M
+$206.00 K+8.53%

December 31, 2023

Summary

Performance

1-Year Change

+8.53%

3-Year Change

+69.16%

5-Year Change

+40.97%

15-Year Change

+34.74%

AXDX Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

32.45%
AXDX annual accounts receivable is higher than 32.45% of companies in Healthcare sector

High & Low

All-time High

$3.22 M
AXDX annual accounts receivable is currently -18.62% below its historical high of $3.22 million

3-Year Low

$2.32 M
AXDX annual accounts receivable is currently +13.02% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
AXDX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 28, 2025
AXDX next annual earnings announcement is scheduled for Mar 28, 2025

OtherAXDXbalance sheetmetrics:

Annual Accounts Payable

$4.80 M
AXDX annual accounts payable is $4.80 million

Annual Total Assets

$31.37 M
AXDX annual total assets is $31.37 million

Annual Total Liabilities

$51.25 M
AXDX annual total liabilities is $51.25 million

Annual Cash & Cash Equivalents

$12.14 M
AXDX annual cash & cash equivalents is $12.14 million

Quarterly Accounts Receivable

$2.03 M
-$262.00 K-11.45%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

AXDX Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

29.37%
AXDX quarterly accounts receivable is higher than 29.37% of companies in Healthcare sector

High & Low

All-time High

$3.22 M
AXDX quarterly accounts receivable is currently -37.09% below its historical high of $3.22 million

3-Year Low

$2.03 M
AXDX quarterly accounts receivable is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AXDX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
AXDX next earnings announcement is scheduled for Mar 28, 2025

OtherAXDXbalance sheetmetrics:

Quarterly Accounts Payable

$4.71 M
AXDX quarterly accounts payable is $4.71 million

Quarterly Total Assets

$32.31 M
AXDX quarterly total assets is $32.31 million

Quarterly Total Liabilities

$80.80 M
AXDX quarterly total liabilities is $80.80 million

Quarterly Cash And Cash Equivalents

$19.69 M
AXDX quarterly cash and cash equivalents is $19.69 million

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

AXDX Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+8.5%0.0%
3 y3 years+69.2%0.0%
5 y5 years+41.0%0.0%

AXDX Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+13.0%-30.9%at low
5 y5-year-18.6%+69.2%-37.1%+30.8%
alltimeall time-18.6%-100.0%-37.1%-100.0%

Accelerate Diagnostics Accounts Receivable History

DateAnnualQuarterly
Sep 2024
-
$2.03 M(-11.4%)
Jun 2024
-
$2.29 M(+3.2%)
Mar 2024
-
$2.22 M(-15.4%)
Dec 2023
$2.62 M(+8.5%)
$2.62 M(-1.7%)
Sep 2023
-
$2.67 M(+13.8%)
Jun 2023
-
$2.34 M(-3.5%)
Mar 2023
-
$2.43 M(+0.5%)
Dec 2022
$2.42 M(+4.1%)
$2.42 M(+1.0%)
Sep 2022
-
$2.39 M(-18.5%)
Jun 2022
-
$2.94 M(+38.8%)
Mar 2022
-
$2.11 M(-8.9%)
Dec 2021
$2.32 M(+49.7%)
$2.32 M(+2.2%)
Sep 2021
-
$2.27 M(+7.3%)
Jun 2021
-
$2.11 M(+7.0%)
Mar 2021
-
$1.98 M(+27.5%)
Dec 2020
$1.55 M(-51.9%)
$1.55 M(-40.6%)
Sep 2020
-
$2.61 M(+0.7%)
Jun 2020
-
$2.59 M(-17.5%)
Mar 2020
-
$3.14 M(-2.5%)
Dec 2019
$3.22 M(+73.2%)
$3.22 M(+22.0%)
Sep 2019
-
$2.64 M(+38.3%)
Jun 2019
-
$1.91 M(-2.0%)
Mar 2019
-
$1.95 M(+4.8%)
Dec 2018
$1.86 M(-4.4%)
$1.86 M(+29.2%)
Sep 2018
-
$1.44 M(-21.0%)
Jun 2018
-
$1.82 M(+71.2%)
Mar 2018
-
$1.06 M(-45.3%)
Dec 2017
$1.95 M(+5623.5%)
$1.95 M(+75.2%)
Sep 2017
-
$1.11 M(+62.9%)
Jun 2017
-
$682.00 K(+23.8%)
Mar 2017
-
$551.00 K(+1520.6%)
Dec 2016
$34.00 K(-55.8%)
$34.00 K(-78.6%)
Sep 2016
-
$159.00 K(-5.9%)
Jun 2016
-
$169.00 K(+119.5%)
Mar 2016
-
$77.00 K(0.0%)
Dec 2015
$77.00 K(-1.3%)
$77.00 K(-89.6%)
Sep 2015
-
$742.00 K(+418.9%)
Jun 2015
-
$143.00 K(+55.4%)
Mar 2015
-
$92.00 K(+17.9%)
Dec 2014
$78.00 K(+225.0%)
$78.00 K(-12.4%)
Sep 2014
-
$89.00 K(+122.5%)
Jun 2014
-
$40.00 K(0.0%)
Mar 2014
-
$40.00 K(+66.7%)
Dec 2013
$24.00 K(-96.9%)
$24.00 K(-77.4%)
Sep 2013
-
$106.20 K(-87.0%)
Jun 2013
-
$818.40 K(+3.1%)
Mar 2013
-
$793.50 K(+5.4%)
Dec 2012
$763.90 K(+1.7%)
-
Oct 2012
-
$753.20 K(+0.3%)
Jul 2012
$750.90 K(-43.9%)
$750.90 K(+25.1%)
Apr 2012
-
$600.00 K(+0.7%)
Jan 2012
-
$595.90 K(-21.7%)
Dec 2011
$1.34 M
-
DateAnnualQuarterly
Oct 2011
-
$760.70 K(+27.6%)
Jul 2011
$596.10 K(+43.4%)
$596.10 K(+39.2%)
Apr 2011
-
$428.30 K(+2.7%)
Jan 2011
-
$417.00 K(-38.0%)
Oct 2010
-
$672.30 K(+61.7%)
Jul 2010
$415.80 K(>+9900.0%)
$415.80 K(+1958.4%)
Apr 2010
-
$20.20 K(+31.2%)
Jan 2010
-
$15.40 K(>+9900.0%)
Jul 2009
$0.00(-100.0%)
$0.00(0.0%)
Apr 2009
-
$0.00(-100.0%)
Jan 2009
-
$50.00 K(+693.7%)
Jul 2008
$6300.00(+12.5%)
$6300.00(-43.8%)
Jan 2008
-
$11.20 K(+100.0%)
Jul 2007
$5600.00(-48.6%)
$5600.00(-67.1%)
Apr 2007
-
$17.00 K(-86.0%)
Jan 2007
-
$121.10 K(+1292.0%)
Oct 2006
-
$8700.00(-20.2%)
Jul 2006
$10.90 K(-75.4%)
$10.90 K(+60.3%)
Apr 2006
-
$6800.00(-16.0%)
Jan 2006
-
$8100.00(-65.4%)
Oct 2005
-
$23.40 K(-47.2%)
Jul 2005
$44.30 K(+178.6%)
$44.30 K(-14.6%)
Apr 2005
-
$51.90 K(-6.0%)
Jan 2005
-
$55.20 K(+380.0%)
Oct 2004
-
$11.50 K(-27.7%)
Jul 2004
$15.90 K(+174.1%)
$15.90 K(-78.9%)
Apr 2004
-
$75.30 K(-34.5%)
Jan 2004
-
$115.00 K(+515.0%)
Oct 2003
-
$18.70 K(+222.4%)
Jul 2003
$5800.00(-76.6%)
$5800.00(-93.9%)
Apr 2003
-
$95.40 K(+17.9%)
Jan 2003
-
$80.90 K(+66.1%)
Oct 2002
-
$48.70 K(+96.4%)
Jul 2002
$24.80 K(-64.3%)
$24.80 K(-25.3%)
Apr 2002
-
$33.20 K(-66.4%)
Jan 2002
-
$98.80 K(+237.2%)
Oct 2001
-
$29.30 K(-57.8%)
Jul 2001
$69.40 K(-75.0%)
$69.40 K(+17.6%)
Apr 2001
-
$59.00 K(-35.7%)
Jan 2001
-
$91.70 K(-42.6%)
Oct 2000
-
$159.80 K(-42.4%)
Jul 2000
$277.20 K(-75.0%)
$277.20 K(+60.0%)
Apr 2000
-
$173.30 K(-68.7%)
Jan 2000
-
$552.80 K(-18.1%)
Oct 1999
-
$674.70 K(-39.1%)
Jul 1999
$1.11 M(+23.1%)
$1.11 M(+8.9%)
Apr 1999
-
$1.02 M(+0.8%)
Jan 1999
-
$1.01 M(+47.4%)
Oct 1998
-
$684.70 K(-23.9%)
Jul 1998
$900.00 K(0.0%)
$900.00 K(-67.4%)
Apr 1998
-
$2.76 M(+26.3%)
Jan 1998
-
$2.19 M(+12.4%)
Oct 1997
-
$1.95 M(+116.2%)
Jul 1997
$900.00 K
$900.00 K

FAQ

  • What is Accelerate Diagnostics annual accounts receivable?
  • What is the all time high annual accounts receivable for Accelerate Diagnostics?
  • What is Accelerate Diagnostics annual accounts receivable year-on-year change?
  • What is Accelerate Diagnostics quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Accelerate Diagnostics?
  • What is Accelerate Diagnostics quarterly accounts receivable year-on-year change?

What is Accelerate Diagnostics annual accounts receivable?

The current annual accounts receivable of AXDX is $2.62 M

What is the all time high annual accounts receivable for Accelerate Diagnostics?

Accelerate Diagnostics all-time high annual accounts receivable is $3.22 M

What is Accelerate Diagnostics annual accounts receivable year-on-year change?

Over the past year, AXDX annual accounts receivable has changed by +$206.00 K (+8.53%)

What is Accelerate Diagnostics quarterly accounts receivable?

The current quarterly accounts receivable of AXDX is $2.03 M

What is the all time high quarterly accounts receivable for Accelerate Diagnostics?

Accelerate Diagnostics all-time high quarterly accounts receivable is $3.22 M

What is Accelerate Diagnostics quarterly accounts receivable year-on-year change?

Over the past year, AXDX quarterly accounts receivable has changed by $0.00 (0.00%)